FDA Drug Approval and the Ethics of Desperation
- PMID: 34694325
- PMCID: PMC8649053
- DOI: 10.1001/jamainternmed.2021.6045
FDA Drug Approval and the Ethics of Desperation
References
-
- Belluck P, Kaplan S, Robbins R. How an Unproven Alzheimer’s Drug Got Approved. New York Times. https://www.nytimes.com/2021/07/19/health/alzheimers-drug-aduhelm-fda.ht.... Published July 19, 2021.
-
- Gingery D Patient Support May Have Helped Push Aduhelm Toward Approval. Pink Sheet Informa Pharma Intelligence. https://pink.pharmaintelligence.informa.com/PS144438/Patient-Support-May.... Published June 7, 2021. Accessed July 16, 2021.
-
- Joseph A Q&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm — and why critics should stop dwelling on the decision. STAT News. https://www.statnews.com/2021/06/16/qa-ceo-alzheimers-association-on-adu.... Published June 16, 2021. Accessed August 29, 2021.
-
- Kapczynski A Dangerous Times: The FDA’s Role in Information Production, Past and Future. Minn L Rev 2017;102:2357.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical